Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Lili Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6621-404X; OpenAlex author ID A5074400978. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper

Papers 2

  1. AREG mediates the epithelial‑mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF‑κB signalling pathway. First author DOI 10.3892/or.2020.7523↗
  2. Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrin… Co-author DOI 10.1016/j.canlet.2017.04.001↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huanwen Wu · 2 shared papers, 2017–2020 · strength 0.20
  2. Junliang Lu · 2 shared papers, 2017–2020 · strength 0.20
  3. Zhiyong Liang · 2 shared papers, 2017–2020 · strength 0.20
  4. Zhiwen Zhang · 1 shared paper, 2020 · strength 0.13
  5. Li Wang · 1 shared paper, 2020 · strength 0.13
  6. Hui Zhang · 1 shared paper, 2017 · strength 0.08
  7. Tonghua Liu · 1 shared paper, 2017 · strength 0.08
  8. Li Wang · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.